BZYR | tickerfilter.com

Fundamental analysis

44%

Profitability 35%

Dept financing 43%

Liquidity 0%

Performance 65%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

3.71%

1 Month

-25.92%

3 Months

-11.03%

6 Months

-27.25%

1 Year

-27.25%

2 Year

-27.25%

Key data

Stock price

$0.04

P/E Ratio

0.00

DAY RANGE

$0.04 - $0.05

EPS

-$0.01

52 WEEK RANGE

$0.03 - $0.06

52 WEEK CHANGE

-$27.25

MARKET CAP

4.601 M

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$19,965

AVERAGE 30 VOLUME

$10,932

Company detail

CEO:
Region: US
Website: burzynskiclinic.com
Employees: 0
IPO year: 2011

Issue type:
Market: OTCM
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. The company is also involved in the production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids.

BZYR - BURZYNSKI RESEARCH INSTITUTE INC